CIK 0000093314
- Non-accelerated filer
- Smaller reporting company
VOLITIONRX LTD
Sign in to watch- Ticker
- VNRX
- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911949078
- Phone
- +1 512-774-8930
- Business address
- 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014
- Former names
- VOLITIONRX LTD, STANDARD CAPITAL CORP
- Open-market buys, last 90 days
- $6,848
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$6,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-22 | Colman Alan Director | Grant or award | +12,000 | 257,364 | ||
| 2025-03-01 | Colman Alan Director | Grant or award | +14,840 | 245,364 | ||
| 2025-01-29 | Colman Alan Director | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2025-01-29 | Colman Alan Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-12-01 | Colman Alan Director | Grant or award | +12,972 | 230,524 | ||
| 2024-09-01 | Colman Alan Director | Grant or award | +13,757 | 217,552 | ||
| 2024-08-15 | Colman Alan Director | Grant or award | +5,000 | 203,795 | ||
| 2024-06-01 | Colman Alan Director | Grant or award | +12,016 | 198,795 | ||
| 2024-01-24 | Colman Alan Director | Grant or award | +8,500 | 186,779 | ||
| 2023-07-05 | Colman Alan Director | Grant or award | +6,750 | 178,279 | ||
| 2023-01-12 | Colman Alan Director | Grant or award | +5,625 | 171,529 |
Page 1 of 1 · 11 trades